Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Tlou Energy says drilling could start at Lesedi in September

2018-08-13 proactiveinvestors.com.au
Tlou Energy Ltd (LON:TLOU) told investors that the first well of its proposed pilot coal bed methane project is expected to spud in September.
TLOU TOU

0
Tlou Energy set to re-tender for Botswana

2018-07-27 proactiveinvestors.com.au
Tlou Energy Ltd (LON:TLOU) has told investors that it is one of two companies that have been invited to re-tender for a coal-bed-methane fueled power projects in Botswana.
TLOU TOU

0
Tlou Energy continues efforts to advance gas-to-power assets

2018-07-25 proactiveinvestors.com.au
Tlou Energy Ltd (LON:TLOU), in its quarterly update, reminded investors that it is working to secure a clear pathway towards a gas-to-power pilot project in Botswana.
TLOU TOU

0
Tlou Energy says core drilling rig has arrived for Lesedi project

2018-07-18 proactiveinvestors.com.au
Tlou Energy Ltd (LON:TLOU) told investors on Wednesday that its core drilling rig has arrived on site of the Lesedi coal bed methane (CBM) project in Botswana.
TLOU TOU

0
Tlou Energy updates on RFP re-tender and plans for Lesedi drilling

2018-07-05 proactiveinvestors.com.au
Tlou Energy Limited’s (LON:TLOU) Colm Cloonan and executive director Gabaake Gabaake spoke to Proactive’s Andrew Scott from Botswana.
TLOU TOU

1
Tlou Energy plans production well drilling at Lesedi for third quarter of 2018

2018-06-28 proactiveinvestors.com.au
Tlou Energy Limited (LON:TLOU ASX:TOU) said it is currently planning a drilling programme for production wells at its Lesedi coal bed methane (CBM) project to start in the third quarter of this year.
TLOU TOU

1
TLOU Energy raises capital to accelerate CBM well plans

2018-06-06 proactiveinvestors.com.au
TLOU Energy Ltd (LON:TLOU) has confirmed a £1.4mln share placing and launched a further share offer seeking to raise a further £3.2mln of new capital.
TLOU TOU

1
Tlou Energy continues to advance Botswana CBM projects

2018-04-23 proactiveinvestors.com.au
Tlou Energy Ltd (LON:TLOU) updated investors on its activities in the three months ended March 31, in which the company focussed on the Lesedi and Mamba coal bed methane (CBM) projects in Botswana.
TLOU TOU

1
Tlou Energy’s Tony Gilby in Botswana to advance grid connection discussions

2018-03-15 proactiveinvestors.com.au
Tlou Energy Ltd's (LON:TLOU) Tony Gilby updates Proactive's Andrew Scott on the re-tendering process with the government in Botswana.
TLOU TOU

Related Articles

REPH: Recro Pharma Analysis and Research Report

20h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

21h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...